|
|
Osiris Therapeutics, Inc. (Inactive Symbol) |
YTD Price Probability |
No random walk data for 2024
|
Default Prediction for 2014-12-31 |
Default prediction by Z-Score (what's this?).
View the other companies in the same industry : N/A
Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):
For manufacuring companies:
Sector Industry |
For non-manufacturing companies:
Sector Industry
|
|
Fundamental Analysis for 2015 |
Fundamental Analysis metrics & ratios (what's this?).
Date of financial statements used: 2015-09-30 |
Book Value: |
$79.8M |
|
Internal Value: |
$79.8M |
|
Working Capital: |
$80.6M |
Debt to Asset Ratio: |
0.210 |
|
Current Ratio: |
5.432 |
|
Turnover Ratio: |
6.405 |
Net Margin: |
-2.6% |
|
EPS: |
-0.076 |
|
P/E ratio: |
-76.181 |
P/B ratio: |
2.504 |
|
ROE: |
-3.3% |
|
ROA: |
-2.6% |
|
|
Company ProfileSymbol: OSIR Market Cap: $199.9M Exchange: NASDAQ Sector: N/A Industry: N/A Data Since: 2007-01-03 Website: www.osiris.com [Web Query] [News Query]
|